How Drug Pooling Improves Supply Efficiency Across Your Clinical Portfolio

Drug supply inefficiencies often stem from inventory being locked to individual studies, creating unnecessary waste in one protocol while another faces shortages. Drug pooling offers a smarter approach by enabling multiple clinical protocols to share a common investigational product inventory, allowing supply to be allocated where patient demand exists in real time. 

By replacing siloed inventory models with a shared pool, sponsors can reduce excess stock, minimize manual reallocations, and improve supply continuity across studies, sites, and countries. The approach supports faster study startup through reusable depot and kit configurations while maintaining traceability, compliance, and inventory control. Key planning considerations include labeling requirements, unique kit naming and serialization strategies, and regulatory approvals across participating regions. 

Organizations managing multiple protocols, investigator-sponsored trials, or lower-enrollment studies can benefit from greater flexibility, reduced drug waste, and more efficient use of valuable clinical supplies. Explore how a pooled inventory strategy can help maximize supply utilization across your portfolio.